Enrollment is now open for our ProLiFiler™ cell panel screening service! Test the efficacy of your cancer therapy candidates and identify the most responsive tumor entities to your drug. Compound submission deadline is March 23.
Learn more: https://t.co/ZmNwFhuuCV
On #RareDiseaseDay we are proud to contribute to the scientific efforts underway to serve patients who are battling diseases with few to no treatment options. Identifying & validating novel treatment targets through #drugdiscovery research is a key part of our mission.
Join us at the XXVII EFMC International Symposium on Medicinal Chemistry conference to learn more about how Reaction Biology can support your next drug discovery project. Learn more about the conference: https://t.co/TWYSWbg0HN
Read our latest blog post to learn why evaluating #kinaseinhibitors in distinct cell-based assay formats allows researchers to examine kinase inhibitors in action from different angles: https://t.co/oLdPHugX79